Breaking News, Promotions & Moves

FUJIFILM Diosynth Biotechnologies Appoints Richard McAvoy CFO

McAvoy will be responsible for financial strategies, financial activities, and financial management contributing to the company’s growth strategy.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

FUJIFILM Diosynth Biotechnologies, a contract development and manufacturing organization (CDMO) for biologics, vaccines, advanced therapies and oncolytic viruses, has appointed Richard McAvoy, currently the Holly Springs, NC site head and vice president of business support, as chief financial officer effective April 1, 2024. McAvoy will be responsible for the company’s financial strategies, overseeing financial activities, and financial management contributing to the company’s growth strategy. M...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters